Myocardial delivery of therapeutic miR-133 via inhalable nanoparticles prevents the pathologic development in a model of ventricular pressure overload

2 September 2019 (09:15 - 09:30)
Organised by:
Congress Presentation Part of: Heart failure: from bench to bed Heart Failure ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by